SRF Ltd (SRF) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- SRF Ltd. navigated a challenging year, marked by initial headwinds in the chemicals business due to external environment and impacting both specialty and fluorochemical segments.
- Despite initial challenges, the company experienced a strong revival in the second half of the fiscal year, particularly in specialty chemicals.
- Revenue increased by 12% to 14,700 crores compared to the previous year.
- EBIT rose by 6% to 2,336 crores, while PAT decreased by 6% to 1,250 crores.
- The company achieved significant milestones, including commissioning of a new AHF plant, which will maximize refrigerant gas details and allow SRF to leverage the quota regime effectively.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.